EGFR and neoplasm: Sharma et al. consistently detected drug-tolerant cancer cell subpopulations in drug-sensitive human tumor cell lines that maintained viability under conditions where the vast majority of cells was rapidly killed after an acute response to various anti-cancer agents, including EGFR-TKI [28].